Drug
Cosyntropin clinical trials
Also written Cortrosyn.
- studies test it
- 14
- open now
- 1
- in phase 3
- 2
- first study started
- 2006
Keep track of what changes. Save the Cosyntropin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
14 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 3
- Phase 2
- 2
- Phase 3
- 2
- Phase 4
- 2
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 14
University of Virginia (2) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1) · Peter y. Liu (1) · Brigham and Women's Hospital (1) · Haukeland University Hospital (1) · Vanderbilt University (1) · University of Michigan (1) · United States Naval Medical Center, San Diego (1)
Often tested with
Tested in the same studies.
Dexamethasone (4) · Ganirelix (2) · Hydrocortisone (2) · Ketoconazole (1) · Lutropin alfa (1) · Metyrapone (1) · Corticorelin ovine (1) · Corticorelin ovine (1)
Studies
Open first, then newest update. How each study uses Cosyntropin is read from its arms, and is right about nine times in ten.
Testing it · 14
- NeSST2: The Development of a Noninvasive Short Synacthen TestRecruitingPhase 2Sheffield Children's NHS Foundation TrustNCT03514589Written as nasal Tetracosactide
- Stress and the Nervous SystemCompletedNot applicableBrigham and Women's HospitalNCT02339506Written as Cosyntropin
- Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal WomenActive, not recruitingEarly Phase 1Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterNCT04037605Written as Cosyntropin Injectable Product
- Hormonal Mechanisms of Sleep Restriction - Axis StudyActive, not recruitingPhase 1Peter y. LiuNCT03142893Written as Cosyntropin Injectable Product
- Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE)TerminatedPhase 2Hospices Civils de LyonNCT02813655Written as Tetracosactide (Synacthène®)
- Mass Spectrometry Based Cutoffs for Cortisol After Stimulation TestsCompletedNot applicableHaukeland University HospitalNCT02818660Written as Synachten
- Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and StimulationActive, not recruitingNot applicableUniversity of VirginiaNCT01421797Written as Cortrosyn
- Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)CompletedNot applicableVanderbilt UniversityNCT01764711Written as Cosyntropin administration
- Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?CompletedPhase 3University of VirginiaNCT03368066Written as Cosyntropin
- A Novel Approach to Infantile SpasmsSuspendedPhase 3University of Colorado, DenverNCT03347526Written as Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin
- Comparison of Intramuscular and Intravenous ACTH Stimulation Test in Normal VolunteersWithdrawnPhase 4Johns Hopkins UniversityNCT03752190Written as Cosyntropin
- Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary MeasuresCompletedPhase 1University of MichiganNCT01673087Written as Cortrosyn
- Cosyntropin Versus Epidural Blood Patch (EBP) for Treatment of Treatment of Post Dural Puncture HeadacheCompletedPhase 4United States Naval Medical Center, San DiegoNCT02394457Written as Cosyntropin
- Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac SurgeryCompletedPhase 1Mayo ClinicNCT01839812Written as Cosyntropin
Given in every arm · 2 — Cosyntropin is usual care beside what is tested
- Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)RecruitingEarly Phase 1Benjamin VigliantiNCT04546126Written as Cosyntropin (Group 3)
- Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen OverproductionWithdrawnEarly Phase 1University of VirginiaNCT01422733Written as Cosyntropin
Codes
What other systems call Cosyntropin · ClinicalTrials.gg INT007267
- MeSH (NLM) D003366CosyntropinConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) 72YY86EA29COSYNTROPINConfirmed FDA, Wikidata
- RxNorm 2890Confirmed FDA, Wikidata
- Wikidata Q560542cosyntropinConfirmed FDA, Wikidata
- NCI Thesaurus C28941CosyntropinOne source FDA
- DrugBank DB01284One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003366 | Cosyntropin | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | 72YY86EA29 | COSYNTROPIN | Confirmed FDA, Wikidata |
| RxNorm | 2890 | — | Confirmed FDA, Wikidata |
| Wikidata | Q560542 | cosyntropin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C28941 | Cosyntropin | One source FDA |
| DrugBank | DB01284 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.